Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide–MHC class II chimera (original) (raw)

• Buzzetti, R., Quattrocchi, C. C. & Nistico, L. Dissecting the genetics of Type 1 Diabetes: relevance for the familial clustering and differences in incidence. Diabetes Metab. Rev. 14, 111–128 (1998).
  Article CAS Google Scholar
• Nepon, G. T. & Erlich, H. MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9, 493–525 (1991).
  Article Google Scholar
• Miyakazi, A. et al. Predominance of T lymphocytes in pancreatic islets and spleen of prediabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol. 60, 622–625 (1985).
  Google Scholar
• Like, A. A., Kislaukis, E., Williams, R. R. & Rossini, A. A. Neonatal thymectomy prevents spontaneous diabetes in the BB/W rat. Science 216, 644–646 (1982).
  Article CAS Google Scholar
• Herold, K. C., Montag, A. G. & Buckingham, F. Induction of tolerance to autoimmune diabetes with islet antigens. J. Exp. Med. 176, 1107–1114 (1992).
  Article CAS Google Scholar
• Serreze, D. V., Leiter, E. H., Worthen, S. M. & Shultz, L. D. NOD marrow stem cells adoptively transfer diabetes to resistant (NOD X NON)F1 mice. Diabetes 37, 252–255 (1988).
  Article CAS Google Scholar
• Wicker, L. S., Miller, B. J. & Muller, Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35, 855–860 (1986).
  Article CAS Google Scholar
• Peterson, J. D., Pike, B., McDuffie, M. & Haskins, K. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice. J. Immunol. 153, 2800–2806 (1994).
  CAS PubMed Google Scholar
• Zekzer, D. et al. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes 46, 1124–1132 (1997).
  Article CAS Google Scholar
• Bowman, M. A., Leiter, E. H. & Atkinson, M. A. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunol. Today 15, 115–120 (1994).
  Article CAS Google Scholar
• Verdaguer, J. et al. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186, 1663–1676 (1997).
  Article CAS Google Scholar
• Bach, J. F. Insulin dependent diabetes as an autoimmune disease. Endocr. Rev. 15, 516–542 (1994).
  Article CAS Google Scholar
• Cameron, M. J. et al. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J. Immunol. 159, 4686–4692 (1997).
  CAS PubMed Google Scholar
• Nitta, Y. et al. Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice. Hum. Gene Ther. 9, 1701–1707 (1998).
  Article CAS Google Scholar
• Nicoletti, F. et al. Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes 48, 2333–2339 (1999).
  Article CAS Google Scholar
• Zaccone, P. et al. Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes 48, 1522–1528 (1999).
  Article CAS Google Scholar
• Piccirillo, C. A., Chang, Y. & Prud' homme, G. J. TGF-β1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J. Immunol. 161, 3950–3956 (1998).
  CAS PubMed Google Scholar
• Yang, X. D. et al. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180, 995–1004 (1994).
  Article CAS Google Scholar
• Herold, K. C. et al. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody. Diabetes 41, 457–464 (1992).
  Article Google Scholar
• Wang, Y., Hao, L., Gill, R. G. & Lafferty, K. J. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36, 535–538 (1987).
  Article CAS Google Scholar
• Shizuku, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K. & Fathman, C. G. Immunotherapy of the nonobese mouse: Treatment with an antibody to T-helper lymphocytes. Science 240, 659–662 (1988).
  Article Google Scholar
• Kuttler, B., Rosing, K., Lehmann, M., Brock, J. & Hahn, H. J. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies. J. Mol. Med. 77, 226–229 (1999).
  Article CAS Google Scholar
• Balasa, B. et al. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159, 4620–4627 (1997).
  CAS PubMed Google Scholar
• Lenschow, D. J. et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181, 1145–1155 (1995).
  Article CAS Google Scholar
• Daniel, D. & Wegmann, D. R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B9-23. Proc. Natl Acad. Sci. USA 93, 956–960 (1996).
  Article CAS Google Scholar
• Tian, J. et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces TH2 responses and prevents murine insulin-dependent diabetes mellitus. J. Exp. Med. 183, 1561–1567 (1996).
  Article CAS Google Scholar
• Tian, R. et al. Modulating autoimmune responses to GAD inhibits disease progression and prolongs graft survival in diabetes-prone mice. Nature Med. 2, 1384–1353 (1996).
  Article Google Scholar
• Maron, R., Melican, N. S. & Weiner, H. L. Regulatory TH2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. J. Autoimmun. 12, 251–258 (1999).
  Article CAS Google Scholar
• Tisch, T., Wang, B. & Serreze, D. V. Induction of glutamic acid decarboxylase 65-specific TH2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J. Immunol. 163, 1178–1187 (1999).
  CAS PubMed Google Scholar
• Elias, D. et al. Vaccination against autoimmune mouse diabetes in young NOD mice with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl Acad. Sci. USA 88, 3088–3091 (1991).
  Article CAS Google Scholar
• Bockova, J., Elias, D. & Cohen, I. R. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces TH2-type antibodies. J. Autoimmun. 10, 323–329 (1997).
  Article CAS Google Scholar
• Petersen, J. S. et al. Treatment with GAD65 or BSA does not protect against diabetes in BB rats. Autoimmunity 25, 129–138 (1997).
  Article CAS Google Scholar
• Funda, D. P., Hartoft-Nielsen, M. L. Kaas, A. & Buschard, K. Effect of intrathymic administration of mycobacterial heat shock protein 65 and peptide p277 on the development of diabetes in NOD mice: caution required in vaccination studies. APMIS 106, 1009–1016 (1998).
  Article CAS Google Scholar
• Ishioka, G. Y. et al. Failure to demonstrate ling-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides. J. Immunol. 152, 4310–4319 (1994).
  CAS PubMed Google Scholar
• Casares, S., Bot, A., Brumeanu, T.-D. & Bona, C. A. Foreign peptides expressed in engineered chimeric self molecules. Biotech. Genet. Engineer. Rev. 15, 159–198 (1998).
  Article CAS Google Scholar
• Casares, S., Bona, C. A. & Brumeanu, T.-D. Engineering and characterization of a murine MHC-immunoglobulin chimera expressing an immunodominant CD4 T viral epitope. Protein Engineer. 10, 1295–1301 (1997).
  Article CAS Google Scholar
• Brumeanu, T. D., Bona, C. A. & Casares, S. T cell tolerance and autoimmune diabetes. Int. Rev. Immunol. 20, 301–323 (2001).
  Article CAS Google Scholar
• Casares, S., Bona, C. A. & Brumeanu, T. D. Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras. Protein Engineer. 14, 195–200 (2001).
  Article CAS Google Scholar
• Casares, S. et al. Antigen specific signaling by a soluble dimeric peptide-MHC class II-Fc chimera leading to TH2 differentiation. J. Exp. Med. 190, 543–553 (1999).
  Article CAS Google Scholar
• Hamad, A. R. et al. Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor. J. Exp. Med. 188, 1633–1640 (1998).
  Article CAS Google Scholar
• Appel, H., Gauthier, L., Pyrdol, J. & Wucherpfennig, K. W. Kinetic of T cell receptor binding by bivalent HLA-DR/peptide complexes that activate antigen-specific human T cells. J. Biol. Chem. 275, 312–321 (2000).
  Article CAS Google Scholar
• Appel, H., Seth, N. P., Gauthier, L. & Wucherpfennig, K. W. Anergy induction by dimeric TCR ligands. J. Immunol. 166, 5279–5285 (2001).
  Article CAS Google Scholar
• Radu, D., Brumeanu, T.-D., McEvoy, R. C., Bona, C. A. & Casares, S. Escape from natural self-tolerance leads to neonatal insulin-dependent diabetes mellitus. Autoimmunity 30, 199–207 (1999).
  Article CAS Google Scholar
• Sarukhan, A. et al. Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. EMBO J. 17, 71–80 (1998).
  Article CAS Google Scholar
• Scott, B. et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1, 73–83 (1994).
  Article CAS Google Scholar
• Lo, D. et al. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur. J. Immunol. 22, 1013–1022 (1992).
  Article CAS Google Scholar
• Bot, A., Casares, S., Bot, S., von Boehmer, H. & Bona, C. A. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR specific for class-II hemagglutinin peptide in CD4+ and CD8+ T cells. J. Immunol. 160, 4500–4507 (1998).
  CAS PubMed Google Scholar
• Sarukhan, A., Garcia, C., Lanoue, A. & von Boehmer, H. Allelic inclusion of T cell receptor alpha genes poses an autoimmune hazard due to low-level expression of autospecific receptors. Immunity 6, 563–570 (1998).
  Article Google Scholar
• Levings, M. K. & Roncarolo, M. G. T-regulatory 1 cells: a novel subset of CD4 T cells with immunomodulatory properties. J. Allergy Clin. Immunol. 106, 109–112 (2000).
  Article Google Scholar
• Rabinovitch, A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 14, 129–151 (1998).
  Article CAS Google Scholar
• Ravetch, J. V. & Bolland, S. IgG Fc receptors. Ann. Rev. Immunol. 19, 275–290 (2001).
  Article CAS Google Scholar
• Weil, R. & Veillette, A. Signal transduction by the lymphocyte-specific tyrosine protein kinase p56lck. Curr. Top. Microbiol. Immunol. 205, 63–87 (1996).
  CAS PubMed Google Scholar
• La Face, D. M. et al. Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. J. Immunol. 158, 2057–2064 (1997).
  CAS PubMed Google Scholar
• Faith, A. et al. An altered peptide ligand inhibits TH2 cytokine synthesis by abrogating TCR signaling. J. Immunol. 162, 1836–1842 (1999).
  CAS PubMed Google Scholar
• Migita, K. et al. Defective TCR-mediated signaling in anergic T cells. J. Immunol. 155, 5083–5087 (1995).
  CAS PubMed Google Scholar
• Madrenas, J., Chau, L. A., Smith, J., Bluestone, J. A. & Germain, R. N. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185, 219–229 (1997).
  Article CAS Google Scholar
• Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742 (1997).
  Article CAS Google Scholar
• Frey, M. et al. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J. Immunol, 161, 400–408 (1998).
  CAS Google Scholar
• Bruunsgaard, H., Pedersen, A. N., Schroll, M., Skinhoj, P. & Pedersen, B. K. Proliferative responses of blood mononuclear cells (PBMC) in a cohort of elderly humans: role of lymphocyte phenotype and cytokine production. Clin. Exp. Immunol. 119, 433–440 (2000).
  Article CAS Google Scholar
• Lepault, F. & Gagnerault, M. C. Characterization of peripheral regulatory CD4 T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol, 164, 240–247 (2000).
  Article CAS Google Scholar
• Seddon, B., Saoudi, A., Nicholson, M. & Mason, D. CD4+CD8− thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. Eur. J. Immunol. 26, 2702–2708 (1996).
  Article CAS Google Scholar
• Alleva, D. G. et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J. Clin. Invest. 107, 173–180 (2001).
  Article CAS Google Scholar
• Wicker, L. S. et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele DRB1*0401. J. Clin. Invest. 98, 2597–2603 (1996).
  Article CAS Google Scholar
• Endl, J. et al. Identification of naturally processed T cells epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99, 2405–2415 (1997).
  Article CAS Google Scholar
• Patel, S. D. et al. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA–DR(α1*0101,β1*0401) transgenic mice. Proc. Natl Acad. Sci. USA 94, 8082–8087 (1997).
  Article CAS Google Scholar